GROWMARK announces new agricultural biologicals manufacturing facility in Missouri
GROWMARK has announced plans to build a new agricultural biologicals manufacturing facility in St. Louis, Missouri. The facility will be constructed at the site of the company’s existing AgraForm operation, which produces and packages insecticides, fungicides, and biological products for agricultural use.
The company, which supplies agricultural products and services, will make an undisclosed investment in the project; job creation figures were not disclosed. The new plant will focus on manufacturing biological crop inputs for agricultural companies that do not have their own production facilities or that require additional manufacturing capacity. The site will also be capable of producing animal biological and waste treatment products.
The St. Louis facility is expected to be operational in early 2027 and will produce biostimulants, biopesticides, and biofertilizers. The press release did not disclose the size of the facility, the amount of land it will occupy, production rates, or details on specific manufacturing technologies to be implemented. No government incentives or public-sector support were cited.
What people are saying
In a recent quote, Rod Wells, Senior Vice President of Strategy and Logistics, GROWMARK, said, "The scientific advancements in agricultural biologicals have introduced innovative methods for farmers to safeguard their plants and improve soil health with more sustainable options. It's beneficial for both farmers and consumers when we enable farmers to grow healthier and stronger crops using these sustainable practices."
Brad Drake, Executive Vice President and Chief Operating Officer, GROWMARK, said, “As demand for biological products continues to grow across the ag industry, the construction of the new manufacturing plant will allow GROWMARK to provide high-quality biological products, made in the United States, to stakeholders throughout North America. It also allows GROWMARK to influence another critical point in the ag value chain to better serve its members and customers.”
Manufacturers investing in Missouri
Sentio BioSciences invests $10.6M to expand pharmaceutical manufacturing facility in Missouri
Sentio’s expansion will increase its domestic manufacturing capacity for generic medicines, including APIs and key starting materials.
Triad Manufacturing invests $1.78M to expand custom retail display manufacturing facility in Missouri
The expanded operations will help Triad Manufacturing meet growing demand while adding 32 new jobs in the region.
Nortian Foodtech invests $22.2M to build protein manufacturing facility in Missouri
The 160,000-square-foot manufacturing facility will transform meat byproducts into high-quality food-grade ingredients.